Page 3 - ஸ்க் உயிர் அறிவியல் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

South Korean vaccine developer SK Bioscience Co Ltd is expected to raise 1.5 trillion won ($1.33 billion) in the country's largest IPO since 2017, after pricing the listing at the top of an indicative range, it said on Monday.

Soult ukpyolsiSouth koreaSouth koreanHimani sarkarJoyce leeThomson reuters trust principlesSk bioscience co ltdThomson reuters trustAsia pacificCorporate eventsBiopharmaceuticals trbc level 5Basic materials trbc level 1Chemicals trbc level 3Company newsCommodity chemicals trbc level 4East asia